Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Passage Bio Inc have a median target of 5.50, with a high estimate of 13.00 and a low estimate of 3.00. The median estimate represents a 797.23% increase from the last price of 0.613.
High | 2,020.7% | 13.00 |
Med | 797.2% | 5.50 |
Low | 389.4% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | +10.19% |
Average growth rate | +11.39% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼